(secondQuint)Over Active Bladder Patients Having Sling Surgery.

 Women with mixed incontinence with primary stress symptoms undergoing Sub-Urethral Sling Procedures will be randomized to peri-operative placebo or solifenacin.

 Subjects in the placebo group will take orally once daily for 9 weeks.

 Subjects in the Solifenacin group will take orally once daily for 9 weeks.

.

 Over Active Bladder Patients Having Sling Surgery@highlight

The purpose of this study is to determine whether treatment with anti-muscarinic medications following sub-urethral sling procedures improves overall subjective and objective outcomes in women with mixed incontinence with primary stress symptoms.

